FK506 (Tacrolimus)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FK506 (Tacrolimus), covering 2014-08-26 to 2014-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX [Phase 2]